|
Hormone Therapy Clinical Trials
5 actively recruiting trials across 3 locations
No change since June 2026
Also known as: Chemotherapy-Hormones/Steroids, Endocrine Therapy, Hormonal, Hormonal Systemic Therapy, Hormonal Therapy +3 more
Pipeline
Phase 2: 3Phase 3: 2
Top Sponsors
- University of Washington1
- Sven Löffeler1
- M.D. Anderson Cancer Center1
- Jonsson Comprehensive Cancer Center1
- David Palma1
Indications
- Cancer5
- Breast Cancer2
- Early Stage HER2-Positive Breast Carcinoma1
- Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v81
- Metastatic Hormone Receptor-Positive Breast Carcinoma1
Other2 trials
Los Angeles, California1 trial
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
UCLA / Jonsson Comprehensive Cancer Center
Phase 2
Houston, Texas1 trial
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
M D Anderson Cancer Center
Phase 2
Seattle, Washington1 trial
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Fred Hutch/University of Washington Cancer Consortium
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.